RxDoctor Payments Data

Bradley White, DO

Family Medicine · Hartwell, GANPI 1396906491

Payments from drug & device makers

$7,413in general payments, 2019–2025

Across 465 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Boehringer Ingelheim$867
  • AstraZeneca$702
  • Sanofi-aventis U.S. LLC$430
  • Bayer$413
  • AbbVie$410
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$7,413100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,413 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$159,651
Medicare patients
396
Services billed
9,476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin96$95,338
MounjaroTirzepatide63$81,116
FarxigaDapagliflozin Propanediol85$67,700
OzempicSemaglutide53$66,649
RybelsusSemaglutide40$56,267
EliquisApixaban79$52,045
Tresiba Flextouch U-200Insulin Degludec28$23,339
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$20,395
RexultiBrexpiprazole14$20,317
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$19,335
KerendiaFinerenone17$17,327
Trijardy XrEmpaglifloz/Linaglip/Metformin18$14,573
GlyxambiEmpagliflozin/Linagliptin19$14,098
LinzessLinaclotide24$13,037
JanumetSitagliptin Phos/Metformin Hcl21$12,536

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Trijardy Xr, Glyxambi$867$124,009133 claims
Novo NordiskOzempic, Rybelsus$1,283$122,91693 claims
AstraZenecaFarxiga, Breztri Aerosphere$702$87,035111 claims
Lilly USA, LLCMounjaro$287$81,11663 claims
PfizerEliquis$253$52,04579 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix$273$34,67154 claims
Otsuka America Pharmaceutical, Inc.Rexulti$192$20,31714 claims
BayerKerendia$413$17,32717 claims
AbbVieLinzess$410$13,03724 claims
MerckJanumet$76$12,53621 claims
Johnson & JohnsonXarelto$92$11,39316 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$430$10,15111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Hartwell

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →